Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Plasma cell 1CNS 1

Conditions

Glioblastoma 8Brain Neoplasms 8Gliosarcoma 5Central Nervous System Neoplasms 5Oligodendroglioma 3Glioma 3Astrocytoma 3Recurrence 2Neuroblastoma 2Neoplasms 2Meningioma 2Medulloblastoma 2Lymphoma 2Choroid Plexus Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pinealoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Liver Neoplasms 1Head and Neck Neoplasms 1

Interventions

Oxaliplatin 2Nivolumab 2Leucovorin 2Irinotecan 2tipifarnib 1entinostat 1Trastuzumab 1Thalidomide 1Temozolomide 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Gemcitabine 1Fluorouracil 1Floxuridine 1Fentanyl 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Cetuximab 1Capecitabine 1Cannabidiol 1CTLA-4 Antigen 1Bortezomib 1Bevacizumab 1Bariatric Surgery 17-hydroxystaurosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gallbladder Neoplasms × Bortezomib × CNS × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡